GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Selwood Asset Management advocates for Louis Hachette market listing change - Global Banking & Finance Review
The image illustrates Selwood Asset Management's proposal for Louis Hachette to change its stock market listing, emphasizing potential growth and visibility in the finance sector.
Finance

Fresenius lifts 2026 expectations after strong Q3

Published by Global Banking & Finance Review

Posted on November 4, 2026

2 min read

· Last updated: November 4, 2026

Add as preferred source on Google

Fresenius Boosts 2026 Earnings Outlook Following Robust Q3 Results

Fresenius Reports Strong Third Quarter and Upgrades Full-Year Guidance

By Tristan Veyet, Kira Britten and Patricia Weiss

Nov 4 (Reuters) - Healthcare group Fresenius lifted its full-year expectations on Wednesday after reporting higher-than-anticipated third-quarter results, as strong performance at the Kabi and Helios divisions supported earnings.

Upgraded Earnings Outlook and Guidance

The company now expects an earnings before interest and tax (EBIT) margin above 11.5%, compared with around 11.5% previously, and 2026 constant-currency core earnings per share (EPS) growth in the upper end of its 10%-15% range.

Second Guidance Upgrade in 2023

The latest guidance upgrade is Fresenius' second this year, after raising its core EPS target in August, as it seeks to improve profitability and reduce debt under CEO Michael Sen's turnaround strategy.

Third Quarter Performance Highlights

Group EBIT Surpasses Expectations

For the third quarter, Fresenius posted earnings before interests and taxes, and special items, of €638 million ($716 million), above the €618.5 million consensus compiled by Vara Research.

Divisional Performance

Kabi Division Drives Growth

Fresenius Kabi generated €391 million in quarterly EBIT, slightly above the €388 million Vara Research consensus and representing more than 60% of the group total, as Kabi plays a growing role in Fresenius' strategy, particularly through its expanding biopharma business.

Helios Division Exceeds Expectations

Hospital operator Helios also beat expectations, reporting EBIT of €293 million in the quarter, 6% above the Vara Research consensus of €277 million, helped by efficiency measures and improving profitability in Germany and Spain.

Comparison with Fresenius Medical Care

Fresenius' results contrast those of former unit Fresenius Medical Care, in which it still owns a 25% stake, after the dialysis specialist cut its operating income outlook following a third consecutive quarterly decline in US treatment volumes.

($1 = 0.8905 euros)

(Reporting by Tristan Veyet and Kira Britten in Gdansk, Patricia Weiss in Frankfurt editing by Bartosz Dabrowski)

Key Takeaways

  • Q3 group EBIT reached €638 million, exceeding the €618.5 million consensus, driven by Fresenius Kabi’s biopharma growth and Helios’s efficiency gains. (ca.marketscreener.com)
  • The company upgraded 2026 guidance for a second time under CEO Michael Sen, aiming for an EBIT margin above 11.5% (previously ~11.5%) and core EPS growth at the upper end of 10%–15%. (ca.marketscreener.com)
  • In contrast, Fresenius Medical Care—a former subsidiary in which Fresenius still holds a 25% stake—narrowed its full‑year outlook due to continued declines in U.S. treatment volumes. (ca.marketscreener.com)

References

Frequently Asked Questions

Why did Fresenius raise its 2026 expectations?
Fresenius lifted its 2026 outlook due to stronger-than-expected Q3 results, mainly driven by solid earnings from its Kabi and Helios divisions.
How did Fresenius perform in the third quarter?
Fresenius reported EBIT of €638 million for the third quarter, surpassing analysts’ expectations and previous guidance.
What divisions contributed most to Fresenius' Q3 earnings?
The Kabi division contributed over 60% of group EBIT, while Helios also exceeded expectations with strong profitability.
What is the revised EBIT margin expectation for Fresenius?
Fresenius now expects an EBIT margin above 11.5%, up from the previously forecasted 11.5%.

Tags

Related Articles

More from Finance

Explore more articles in the Finance category